Invesco Ltd. Amphastar Pharmaceuticals, Inc. Transaction History
Invesco Ltd.
- $460 Billion
- Q2 2024
A detailed history of Invesco Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 450,930 shares of AMPH stock, worth $24.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
450,930
Previous 403,040
11.88%
Holding current value
$24.1 Million
Previous $17.7 Million
1.92%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$317 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$143 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$114 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$104 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$86.6 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.62B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...